Oncogenomics- Genomic Approach to Cancer

Oncogenomics is a subfield of the genomics that characterizes the cancer related genes.  Cancer is a genetic disease induced by accumulation of DNA mutations and epigenetic modifications that contribute to unrestrained cell proliferation and development of neoplasms. The aim of oncogenomics is to discover new genes for oncogenes or tumor suppressors that can provide new insights into cancer identification, predict outcomes of clinical cancer and new targets for cancer treatment.The success of targeted cancer therapies like Gleevec, Herceptin, and Avastin  has increased hopes that oncogenomics will elucidate new targets for cancer care.




  • Medical Oncology
  • Surgical Oncology
  • Cancer Therapy
  • Comparative oncogenomics

Related Conference of Oncogenomics- Genomic Approach to Cancer

September 21-22, 2020

14th International Conference on Genomics & Pharmacogenomics

Vancouver, Canada
September 23-24, 2020

24th European Biotechnology Congress

Berlin, Germany
October 19-20, 2020

7th Asia Pacific Geriatrics and Gerontology Congress

Tokyo, Japan
October 23-24, 2020

2nd International Conference on Biomarkers and Cancer Targets

Cape Town, South Africa
November 16-17, 2020

International Conference on Genomics and Molecular Biology

Lisbon, Portugal
November 19-20, 2020

24th European Biotechnology Congress (EBC_2020)

London, UK
November 23-24, 2020

International Conference on Toxicogenomics

Bali, Indonesia
December 07-08, 2020

2nd World Congress on Cell and Structural Biology

Sydney, Australia

Oncogenomics- Genomic Approach to Cancer Conference Speakers

Recommended Sessions

Related Journals

Are you interested in